Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tejocote root is an herbal dietary supplement derived from the root of the *Crataegus mexicana* (Mexican hawthorn) tree. It is primarily marketed as a natural weight loss aid and detoxification supplement, particularly popular in Mexico and the United States. The supplement is not a pharmaceutical drug and has not been evaluated or approved by the FDA for safety or efficacy in treating any medical condition. It contains various plant-derived compounds such as pectin, vitamin C, and flavonoids. However, it has been linked to serious adverse events, including cardiac toxicity, hepatotoxicity, and thrombocytopenia. A significant safety concern involves the frequent adulteration of tejocote root products with yellow oleander (*Thevetia peruviana*), a highly toxic plant containing cardiac glycosides that can cause life-threatening arrhythmias.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tejocote root.